Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia

Tropical Biomedicine

Volumn 29, Issue 1, 2012, Pages 151-159

  Emelia, O ^a   Amal, R N ^b   Ruzanna, Z Z ^c   Shahida, H ^a   Azzubair, Z ^a   Tan, K S ^a   Noor Aadila, S ^a   Siti, N A M ^a   Aisah, M Y ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; AGE; ANIMAL; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; ETHNIC GROUP; FEMALE; HUMAN; IMMUNOLOGY; MALAYSIA; MALE; MIDDLE AGED; RISK FACTOR; SCHIZOPHRENIA; TOXOPLASMA; TOXOPLASMOSIS;

ADULT; AGE FACTORS; ANIMALS; ANTIBODIES, PROTOZOAN; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUPS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALAYSIA; MALE; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84859081878     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ahmad Daryani, Mehdi, S., Sayed, H.H., Sayed, A.K. & Shirzad, G. (2010). Serological survey of Toxoplasma gondii in schizophrenia patients referred to Psychiatric Hospital, Sari City, Iran. Tropical Biomedicine 27(3): 476-482.
2. Burmeister, M., Mclnnis, M.G. & Zollner, S. (2008). Psychiatric genetics: progress amid controversy. Nature Reviews Genetics 9: 527-540.
3. Centikaya, Z., Suleyman, Y., Gerici, O. & Namli, M.N. (2007). Anti-Toxoplasma gondii antibodies in patients with schizophrenia-preliminary findings in a Turkish sample. Schizophrenia Bulletin 33(3): 789-791.
4. Daubener, W. & Hadding, U. (1997). Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system. Medical Microbiology and Immunology 185: 195-206.
5. Daubener, W., Spors, B., Hucke, C., Adam, R., Stins, M., Kim, K.S. & Schroten, H. (2001). Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infection and Immunity 69: 6527-6531.
6. Dawson, D. (2005). Foodborne protozoan parasites. International Journal of Food Microbiology 103: 207-27.
7. Delgado, G.G. (1979). Toxoplasmosis y enfermedades mentales. Revista Cubana de Medicina Tropical 31: 127-13.
8. Dogruman-al, F., Aslan, S., Yalcin, S., Kustimur, S. & Turk, S. (2009). A possible relationship between Toxoplasma gondii and schizophrenia: A seroprevalence study. International Journal of Psychiatry in Clinical Practice 13(1): 82-87.
9. Dubey, J.P. (2004). Toxoplasmosis-A waterborne zoonosis. Veterinary Parasitology 126: 57-72.
10. Fischer, H.G., Nitzgen, B., Reichmann, G., Gross, U. & Hadding, U. (1997). Host cells of Toxoplasma gondii encystations in infected primary culture from mouse brain. Parasitology Research 83: 637-641.
11. Flegr, J., Press, M., Klose, J., Havlicek, J., Vitakova, M. & Kodym, P. (2003). Decreased level of psycholobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii. Dopamine, a missing link between schizophrenia and toxoplasmosis? Biological Psychology 63: 253-268.
12. Flegr, J., Zikova, S., Kodym, P. & Frynta, D. (1996). Induction of changes in human behavior by the parasitic protozoan Toxoplasma gondii. Parasitology 113: 49-54.
13. Fujigaki, S., Saito, K., Takemura, M., Maekawa, N., Yamada, Y., Wada, H. & Seishima, M. (2002). L-tryptophan-Lkynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: crossregulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infection and Immunity 70: 779-786.
14. Fujigaki, S., Takemura, M., Hamakawa, H., Seishima, M. & Saito, K. (2003). The mechanism of interferon-gamma induced anti Toxoplasma gondii by 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues. Advances in Experimental Medicine and Biology 527: 97-103.
15. rdEd. American Society for Microbiology Press.
16. Washington D.C. Havlicek, J., Gasova, Z., Smith, A.P., Zvara, K. & Flegr, J. (2001). Decrease of psychomotor performance in subjects with latent asymptomatic toxoplasmosis. Parasitology 122: 515-520.
17. Halonen, S.K., Lyman, W.D. & Chiu, F.C. (1996). Growth and development of Toxoplasma gondii in human neurons and astrocytes. Journal of Neuropathology and Experimental Neurology 55: 1150-1156.
18. Hinze-Selch, D., Daubener, W., Eggert, L., Erdag, S., Stoltenberg, R. & Wilms, S.A. (2007). Controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: Beyond seroprevalence. Schizophrenia Bulletin 33: 782-788.
19. Jones-Brando, L., Torrey, E.F. & Yolken, R.H. (2003). Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophrenia Research 62(3): 237-244.
20. Kocher, R., Kaeser, H.E. & Wurmser, P. (1969). Zur Er-wachsenentoxoplasmose des ZNS. Praxis 14: 427-437.
21. Leweke, F.M., Gerth, C.W., Koethe, D., Klosterkötter, J., Ruslanova, I., Krivogorsky, B., Torrey, E.F. & Yolken, R.H. (2004). Antibodies to infectious agents in individuals with recent onset schizophrenia. European. Archives of Psychiatry and Clinical Neuroscience 254: 4-8.
22. Luder, C.G., Giraldo-Velasquez, M., Sendter, M. & Gross, U. (1999). Toxoplasma gondii in primary rat CNS cells: Differential contribution of neurons, astrocytes, and microglial cells, for the intracerebral development and stage differentiation. Experimental Parasitology 93: 23-32.
23. Miller, C.L., Llenos, I.C., Dulay, J.R., Barillo, M.M., Yolken, R.H. & Weis, S. (2004). Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiology of Disease 15: 618-629.
24. Minto, A. & Roberts, F. (1959). The psychiatric complications of toxoplasmosis. Lancet 1: 1180-1182.
25. Montoya, J.G. & Liesenfield, O. (2004). Toxoplasmosis. Lancet 363(9425): 1965-1976.
26. Mortensen, P.B., Norgaard-Pedersen, B., Waltoft, B.L., Sorensen, T.L., Hougaard, D. & Yolken, R.H. (2007). Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophrenia Bulletin 10: 1093.
27. Mortensen, P.B., Pedersen, C.B., Westergaard, T., Wohlfahrt, J., Ewald, H., Mors, O., Andersen, P.K. & Melbye, M. (1999). Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 340: 603-608.
28. Nissapatorn, V. & Khairul, A.A. (2004). Review on human toxoplasmosis in Malaysia: The past, present and prospective future. South East Asian Journal of Tropical Medicine and Public Health 35(1): 24-35.
29. Oberdorfer, C., Adams, O., MacKenzie, C.R., De Groot, C.J. & Daubener, W. (2003). Role of IDO activation in anti-microbial defense in human native astrocytes. Advances in Experimental Medicine and Biology 527: 15-26.
30. Quiying, L., Xiaonian, L. & Li, L. (1999). The control study of schizophrenia and affective disorder and Toxoplasma infections. Acta Academiae Medicinae Hube 20: 223-225.
31. Robert, S. & Christopher, A.H. (2007). Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid? Schizophrenia Bulletin 33(3): 652-653.
32. Saraei-Sahnesaraei, Shamloo, M., Jahani Hashemi, F., Khabbaz, H.F. & Alizadeh, S.A. (2009). Relation between Toxoplasma gondii infection and schizophrenia. Iranian Journal of Psychiatry and Clinical Psychology 15(1): 3-9.
33. Sheehan, D., Janavs, J., Harnett-Sheehan, K., Sheehan, M. & Gray, C. (2009). Mini International Neuropsychiatric Interview (MINI) English version 6.0.0 DSM-IV.
34. Tan, D.S.K., Zaman, V. & Lopes, M. (1978). Infectious mononucleosis or toxoplasmosis? Medical Journal of Malaysia 33: 23-55.
35. Thomas, V., Sinniah, B. & Yap, P.L. (1980). Prevalence of antibodies including IgM to Toxoplasma gondii in Malaysia. Southeast Asian Journal of Tropical Medicine and Public Health 11: 119-125.
36. Torrey, E.F. & Yolken, R.H. (2001). The schizophrenia-rheumatoid arthritis connection: Infectious, immune, or both? Brain, Behavior, and Immunity 15: 401-410.
37. Torrey, E.F. & Yolken, R.H. (2003). Toxoplasma gondii and schizophrenia. Emerging Infectious Diseases 9(11): 1375-1380.
38. Webster, J.P., Lamberton, P.H., Donnelley, C.A. & Torrey, E.F. (2006). Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proceeding of the Royal Society Biological Science 273(1589): 1023-1030.
39. Yolken, R.H., Bachmann, S., Rouslanova, I., Lillehoj, E., Ford, G., Torrey, E.F. & Schroeder, J. (2001). Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infectious Diseases 32(5): 842-844.